Dianthus Therapeutics | MGTA - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Avita Medical AUD -11.64M 12.13M 2025-12
Celltrion KRW 11.84B 1.34B 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 11.8B 2.17B 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Moderna USD -1.33B 535M 2026-03
Neuren Pharmaceuticals AUD 19.21M 9.35M 2025-12
Organigram Holdings CAD -921K 40.8M 2026-03
Organon & Co USD 183M 30M 2026-06
Pharma Mar EUR -993K 2.59M 2026-06
Qiagen NV USD 157.9M 72.08M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Sartorius EUR 127M 30.8M 2026-06
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Viatris USD -247.3M 95.7M 2026-03
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03
Zealand Pharma A/S -394M 12.5M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03